Research / FTI / Fundamental state Inspectable configuration
State dimensions Filing 0001681459-26-000045 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
14.55% · OPTIONAL · VALID
Capex intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.17% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.83% · OPTIONAL · VALID
Revenue growth 35th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
9.01% · CORE · VALID
Inventory pressure 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
44.97% · OPTIONAL · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
19.02% · CORE · VALID
R&D intensity 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.93% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 16.87%
Current 14.55%
Delta -2.32% Capex Intensity Decreased
Previous 2.23%
Current 2.17%
Delta -0.06% Cash Generation Increased
Previous 13.34%
Current 19.83%
Delta 6.49% Growth Decreased
Previous 11.60%
Current 9.01%
Delta -2.59% Inventory Pressure Decreased
Previous 49.10%
Current 44.97%
Delta -4.13% Profitability Increased
Previous 15.49%
Current 19.02%
Delta 3.53% R And D Intensity Increased
Previous 0.71%
Current 0.93%
Delta 0.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2026
Similarity 76%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Profitability 10.0 · Capex Intensity 5.0 · Cash Generation 20.0 · R And D Intensity 50.0 · Inventory Pressure 15.0 · Balance Sheet Leverage 5.0 Mar 31, 2025
Similarity 72%
Compared 7 dimensions
Coverage 100% Growth 20.0 · Profitability 20.0 · Capex Intensity 50.0 · Cash Generation 5.0 · R And D Intensity 40.0 · Inventory Pressure 20.0 · Balance Sheet Leverage 10.0 Sep 30, 2025
Similarity 71%
Compared 7 dimensions
Coverage 100% Growth 30.0 · Profitability 0.0 · Capex Intensity 55.0 · Cash Generation 5.0 · R And D Intensity 45.0 · Inventory Pressure 0.0 · Balance Sheet Leverage 5.0 Sep 30, 2024
Similarity 70%
Compared 7 dimensions
Coverage 100% Growth 40.0 · Profitability 0.0 · Capex Intensity 15.0 · Cash Generation 10.0 · R And D Intensity 65.0 · Inventory Pressure 15.0 · Balance Sheet Leverage 10.0 Dec 31, 2022
Similarity 69%
Compared 7 dimensions
Coverage 100% Growth 35.0 · Profitability 45.0 · Capex Intensity 15.0 · Cash Generation 20.0 · R And D Intensity 50.0 · Inventory Pressure 10.0 · Balance Sheet Leverage 15.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.